{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"PancChat Podcast with Alisyn Camerota","title":"Managing Diabetes During Treatment","html":"","width":"100%","height":180,"duration":1843,"description":"Diabetes and pancreatic cancer often go hand in hand. Between 30 to 50% of patients have diabetes or prediabetes at diagnosis, and another 40% develop it during treatment.\nTo get the latest information, host Alisyn Camerota is joined by endocrinologist and Director of the Duke Onco-Endocrinology Program at the Duke Center for Cancer Immunotherapy, Dr. Afreen Shariff, an Associate Director for the Cancer Therapy Toxicity Program and a member of the faculty in the Division of Endocrinology, Diabetes, and Metabolism at Duke University School of Medicine.\nIn this episode, Dr. Shariff discusses managing pancreatic cancer and diabetes, and how surgery, chemotherapy, and radiation can all affect blood sugar as a direct, on-target effect of treatment. She emphasizes working with an endocrinologist and oncologist to help control diabetes during and after treatment.\nHer advice: get a clear diagnosis, know your numbers, and don't hesitate to bring up blood sugar concerns with your oncology team.\nPancChat is produced in collaboration with Let's Win Pancreatic Cancer and PanCAN.\nThis episode is sponsored by Revolution Medicines.\nFor more information, visit letswinpc.org and pancan.org.\nRESOURCES:\nLet's Win's Diabetes Section\nPancCAN Diabetes and Pancreatic Cancer\nPanCAN Patient Services\nLet's Win Doctor Finder\nLet's Win Clinical Trial Finder\nPanCAN Clinical Trial Finder","thumbnail_url":"https://img.transistorcdn.com/cAJEAPlDE1maKBGcgHeLPBFdNegZ6bz0Ol0rS-Dsvj0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZThh/MzliZmRmOThiY2U5/ZGNlNWI0MGE2Mjdj/NDkzMy5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}